Cytotoxic Effect of Capsicum annum L. extract on T47D Cells:
In vitro Study
Rochmah Kurnijasanti1*, Amaq Fadholly2
1Department of Veterinary Basic Medicine, Faculty of Veterinary Medicine,
Universitas Airlangga, Surabaya, 60115, Indonesia.
2Doctoral Program in Veterinary Science, Faculty of Veterinary Medicine,
Universitas Airlangga, Surabaya, 60115, Indonesia.
*Corresponding Author E-mail: rochmah-k@fkh.unair.ac.id
ABSTRACT:
Capsicum annum L. is a potential natural plant that have a lot of various pharmacological effects, including as anticancer agent. This study Aim to analyze Capsicum annum extract (CAE) on T47D cells. CAE (10, 20, 40, 60, 80µg/mL) treated on T47D cells to determined IC50 value by MTT assay. Apoptosis induction is also investigated through caspase-3 expressions (IC50, 2IC50). The present study showed that CAE suppress T47D cells proliferation with IC50 value of 75.81µg/mL. The caspase-3 expression on 2IC50 is higher (67.16%) than IC50 (52.16%). This result indicate that CAE has ability as anticancer agent by inhibiting cell growth and induce apoptosis through caspase-3 expression on T47D cells. Further study of CAE holds potential for novel therapies of cancer prevention and treatment.
KEYWORDS: Capsicum annum, Cytotoxicity, Apoptosis.
INTRODUCTION:
Cancer is defined as the abnormal cells division without control that generally occurs over an extended period of time. Breast cancer is the most frequently diagnosed cancer in females (25%) worldwide. Most breast cancer occur 100 times higher in women than that in men1. Breast cancer develops through a multistep process and the pathogenesis of this disease has not yet been elucidated2. Breast cancer incidence rates increased among Asian/Pacific women and non-Hispanic black, while were stable among non-Hispanic white, Hispanic and American Indian native women. Breast cancer is a metastatic cancer and can commonly transfer to distant organ such as the bone, brain, lung and liver3. Cancer metastasis is responsible for more than 90% of cancer-related death. Breast cancer is commonly associated with sex, estrogen, unhealthy lifestyle, family history and gene mutation4.
Normally, surgery, chemotherapy, and radiation are allowed for breast cancer therapy. However, those methods have limitation for uncontrolling toxicity for normal cells. Doxorubicin is a chemotherapy drug used in the treatment of several cancers including breast cancer. It acts on cancer cells through intercalation into DNA resulting in the inhibition DNA synthesis and function leading to eventual DNA breaks5. Although doxorubicin has a lot of beneficial, however the discovery of new drug as alternative way to cure cancer is highly needed. Plants are regarded as a prospective source for cancer treatment due to various therapeutic effects. Over 60% of the currently used anticancer agents are derived in one way or another from natural sources6.
Capsicum annum L. commonly known as bell pepper exhibits proven health as well as medicinal significance. It can be consumed either in fresh (salads, salsa, pizza) or processed form as dried powder7. Capsicum annum belongs to the family of Solanaceae that contain flavonoids, phenolics, carotenoids, alkaloids, and rich source of vitamin C, provitamin A, and calcium. Array of bioactive compounds suggest it a choice for preventing cell damage, cancer insurgence, diabetes prevalence, cataracts, cardiovascular disorders, Alzheimer’s and Parkinson’s disease. The principal ingredient present in this species is capsaicin (trans-8-methyl-N-vanillyl-6-non-enamide). The capsaicin content varies from 0,1% to 1% that recently attracted considerable attention because its anticancer properties to selectively inhibit the growth of tumor cells, both in vitro and in vivo8. Despite the several known effects of naringin, this study needs more validation as anticancer compound. Recently, we describe that Capsicum annum extract (CAE) inhibited tumor growth and apoptosis induction shown in caspase-3 expression on T47D cells.
MATERIAL AND METHODS:
Ethical Clearance:
All treatment procedures under guided The Medical and Health Research Ethics Committee (MHREC), Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Indonesia.
Preparation of Capsicum annum extract:
Capsicum annum L. were obtained from Surabaya, East Java, Indonesia. They were cleaned and chopped into small pieces and shade-dried. They were mashed to powdery form using a mechanical blender and passed through the coarse sieve (0.2mm). The Capsicum annum L. powder was macerated with ethanol 96% for 72 h at 37°C. The extract was evaporated in water bath at 60°C. The residue was stored in a refrigerator at - 4°C.
Cell culture of T47D cells:
T47D cells were obtained from Parasitology Laboratory, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Indonesia. Cells were cultured in dulbecco’s modified eagle medium (DMEM) media that supplemented with fetal bovine serum 10% (v/v), streptomycin-penicillin 3% and fungizone 1% then incubated in incubator CO2 5% at 37°C. Cells were collected after reaching 80% on confluency using trypsine - EDTA 0, 25%.
Cytotoxic assay evaluation:
T47D cells 5 x 103 cells/well were implanted into 96-well plate, respectively, then incubated in incubator CO2 5% at 37°C overnight. Cells were added with five various concentration of Capsicum annum extract (10, 20, 40, 60, 80µg/mL) for 24 h. MTT reagent (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 100 mL were added into each well. The cells were incubated one more time for 4 h until formazan crystals were formed. SDS-stopper HCL 0,1 N were also added to evaluate the colours for the media. The plate was wrapped in aluminium foil and incubated in dark place overnight. Colour absorption were read by ELISA reader at λ 595nm. The inhibitory concentration 50 (IC50) value were calculated using linear regression of log concentration. Other cells, T47D and Vero were done with same method, respectively.
Caspase-3 staining evaluation:
T47D cells were implanted in six wells 5 x 105 cells/well using sterile coverslip as a microplate and incubated in incubator CO2 5% at 37°C overnight. The two concentration of Capsicum annum extract (IC50, 2IC50) were added in each well for 24 h. The cells were harvested and washed with PBS twice. The cold methanol were used to fixed the cells for 10 min. Then, the cells in coverslip were placed each on a respective slide. The cells were washed with PBS twice. Hydrogen peroxide blocking solution were added to blocked the cells for 10 min. The cells were washed again with PBS pH twice. The primary antibody (caspase-3) was added on cells for 60 min, then washed with PBS twice. Polymer neopoly was added on cells for 30 min, then washed with PBS twice. DAB was added for 3 min, then washed with distilled water for 5 min. Cells were counterstained with hematoxylin for 2 min, then washed with distilled water. The cells were immersed in absolute ethanol and in xylol afterward. The protein expression were analyzed under the microscope.
RESULTS AND DISCUSSION:
The viability of T47D cells were measured using MTT assay to determine the IC50 of Capsicum annum extract treatment. The result showed that all various concentrations of CAE inhibited cell growth of T47D cells. The highest viability of T47D cells is 93.16% at dose of 10µg/mL. The lowest viability is 38.01% at dose of 80µg/mL. The viability of T47D cells from three other concentrations 20µg/mL, 40µg/mL and 60µg/mL are 86.11%, 75.18%, and 52,19%. Doxorubicin also decreases the growth of T47D cells (Figure 1). Meanwhile, the results of viability on Vero cells also decrease at dose-dependent manner, 92.67%, 88.92%, 84.88%, 84.88%, 81.07%, respectively. Doxorubicin also decrease Vero cells (Figure 2). The IC50 of CAE on T47D cells is 75.81µg/mL.
Figure 1: Viability responses of CAE and doxorubicin on T47D cells.
Figure 2: Viability responses of CAE and doxorubicin on Vero cells.
Breast tumor usually start from the ductal hyperproliferation, then develop into benign tumors or carcinoma after constantly by various carcinogenic factors9. In this study, the cytotoxic effect of Capsicum annum extract (CAE) against T47D cells as mammary tumor cell lines is investigated. CAE inhibit the growth of T47D cells with IC50 value 75.81µg/mL. This result indicates CAE potent to develop as anticancer agent. Cytotoxic activity of CAE by the content of bioactive compounds that have anticancer effects. Among the bioactive compounds isolated from CAE which has most dominant anticancer activity is capsaicin. Diverse studies have shown that capsaicin has antiproliferative effect on several human cell lines derived from multiple myeloma, pancreatic cancer, prostate cancer, colon cancer, lung cancer and gastric cancer10,11,12.
As shown in Figure 3, the exposure of T47D cells to IC50 and 2IC50 naringin for 24 h enhanced the number of caspase-3 expression, typical brown colour in cytoplasm of cells. The dose of 2IC50 (67.16%) is higher than dose of IC50 (52.16%). Control cells were not induced apoptosis due to the cells were not treated with CAE.
Figure 3: The effects of CAE on T47D cells.
The untreated group (a); The caspase-3 expression (black arrow) shown in brown colour in cytoplasm of IC50 (b); 2IC50 (c); B: The bars represent mean ± SD of caspase-3 scores. The data is the mean (n=3) with *p value ≤ 0.05 when compared to IC50 value.
A successful anticancer property should kill cancer cell without causing damages to normal cells. Determining the molecular targets involved in the tumor development process will also provide opportunities to develop cancer–fighting strategy. Caspase-3 is apoptosis marker that leading cell death without making inflammation around the normal cell. This ideal situation is achievable by inducing apoptosis in cancer cells13,14. This study showed that the expression of caspase-3 of the CAE treatment 2IC50 were higher compared to IC50. These data clarify that CAE induced apoptosis through caspase-3 expression. Apoptosis is an essential barrier against cancer development and progression and loss of apoptotic signaling is highly associated with malignancy15. Previous studies reported that genus of capsicum induce apoptosis through activate caspase-3 protein in HepG2 and Hep3B cells16,17. Capsaicin may also serve as an antitumorigenic agent in human gastric cancer due to expression of proapoptotic protein such as Bax, caspase-3 and caspase-818. Other studies showed that capsaicin induced apoptosis and cell cycle arrest at G1 phase in A172 human glioblastoma cells, PANC-1 and NPC-TW 039 cells19,20.
Other compounds also supported CAE as anticancer properties, suh us flavonoids express wide variety of biological effects that may play a role in cancer therapy. It reveals potent antiproliferative, antiangiogenic, induce apoptosis and perturb cell cycle progession21. Prior studies demonstrated that phenolic exhibit anticarcinogenic, induce cell ceycle arrest, inhibit oncogenic signaling cascade controlling cell proliferation, angiogenesis and apoptosis22. Carotenoids showed its ability inhibit the proliferation of several types of cancer cells and induced apoptosis on the cells23. Alkaloids also captures antineoplastic effect on various cancer cells24.
CONCLUSION:
This study revealed that Capsicum annum extract (CAE) inhibit cell growth with IC50 75.81µg/mL and activate caspase-3 expression as an apoptosis marker on T47D cells. It is a interesting natural source to be developed as an anticancer properties. Further study of CAE can be modified in concentration to find the best result of cancer prevention and treatment.
ACKNOWLEDGEMENT:
Authors would like to thank the Departments of Veterinary Basic Medicine, Faculty of Veterinary Medicine, Universitas Airlangga. Special thanks to PMDSU Scholarship by The Ministry of Research, Technology, and Higher Education of the Republic of Indonesia which was awarded to Amaq Fadholly.
CONFLICT OF INTEREST:
The authors declare no conflict of interest.
REFERENCES:
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J. Clin. 2017; 67: 7-30.
2. Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin. Obstet. Gynecol. 2016; 59(4): 651-672.
3. DeSantis CE, Fedewa SA, Sauer AG, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J. Clin. 2016; 66(1): 31-42.
4. Xu G, Ye D, Zhao Q, He R, Ma W, Li Y, Tang S, Zhou Z, Li X, Zhang Z. circNFIC suppresses breast cancer progression by sponging miR-658. J. Cancer. 2020; 11(4): 4222-4229.
5. Yurtcu E, Iseri OD, Sahin FI. Effects of silymarin and silymarin-doxorubiin applications on telomerase activity of human hepatocellular carcinoma cell line HepG2. J. BUON. 2015; 20(2): 555-561.
6. Fadholly A, Ansori ANM, Jayanti S, Proboningrat S, Kusala MKJ, Putri N, Rantam FA, Sudjarwo SA. Cytotoxic effect of Allium cepa L. extract on human colon cancer (WiDr) cells: in vitro study. Research J. Pharm. and Tech. 2019; 12(7): 3483-3486.
7. Shaimaa GA, Mahmoud MS, Mohamed MR, Emam AA. Phytochemical screening, antioxidant activities and in vitro anticancer potential of Egyptian capsicum spp. Biochem. Phamacol (Los Angel). 2016; 5(2): 1000205.
8. Yang J, Luo B, Xu G, Li T, Chen Y, Zhang T. Low-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathways. Neoplasma. 2013; 60: 364-372.
9. Sonnenschein C, Soto AM. Carcinogenesis explained within the context of a theory of organisms. Prog. Biophys. Mol. Biol. 2016; 122(1): 70-76.
10. Brown KC, Witte TR, Hardman WE, Luo H, Chen YC, Carpenter AB, Lau JK, Dasgupta P. Capsaicin displays antiproliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PloS ONE. 2010; 5: e10243.
11. Lu HF, Chen YL, Yang JS, Yang YY, liu JY, Hsu SC, Lai KC, Chung JG. Antitumor activity of capsaicin on human colon cancer cells in vitro and colo2015 tumor xenografts in vivo. J. Agric. Food. Chem. 2010; 58: 12999-13005.
12. Amruthraj NJ, Raj JP, Saravanan S, Lebel LA. In vitro studies on anticancer activity of capsaicinoids from capsicum Chinese against human hepatocellular carcinoma cells. Int. J. Pharm. Pharm. Sci. 2014; 6(4): 254-558.
13. Gavamukulya Y, Wamunyokoli F, El-Shemy HA. Annona muricata: is the natural therapy the most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac. J. Trop. Med. 2017; 10(9): 853-848.
14. Fadholly A, Ansori ANM, Proboningrat A, Nugraha AP, Iskandae RPD, Rantam FA, Sudjarwo SA. Apoptosis of HeLa cells via caspase-3 expression induced by chitosan-based nanoparticles of Annona squamosa leaf extract: in vitro study. Indian J. Pharm. Educ. Res. 2020; 54(2): 416-422.
15. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674.
16. Moon DO, Kang CH, Kang SH, Cjoi YH, Hyun JW, Chang WY, Kang HK, Koh YS, Maeng YH, Kim YR, Kim GY. Capsaicin sentizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca2+ inflx. Toxicol. Appl. Pharmacol. 2012; 259: 87-95.
17. Chen X, Tan M, Feng B, Zhao Z, Yang K, Hu C, Liao N, Wang T, Chen D, Xie F, Tang C. Inhibiting ROS-STAT3-dependent autophagy enhanced capsaicin-induced apoptosis in human hepatocellular carcinoma cells. Free Radic. Res. 2016; 7: 744-755.
18. Arnab S, Bhattacharjee S, Mandal DP. Induction of apoptosis by eugenol and capsaicin in human gastric cancer AGS cells-elucidating the role of p53. Asian Pac. J. Cancer Prev. 2015; 16: 6753-6759.
19. Ip SW, Lan SH, Lu HF, Huang AC, Yang JS, Lin JP, Huang HY, Lien JC, Ho CC, Chiu CF, Wood W, Chung JG. Capsaicin mediates apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells through mitochondrial depolarization and endoplasmic reticulum stress. Hum. Exp. Toxicol. 2011; 11: 539-549.
20. Zhang JH, Lai FJ, Chen H, Luo J, Zhang RY, Bu HQ, Wang ZH, Lin HH, Lin SZ. Involvement of the phosphoinositide 3-kinase/ Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1. Oncol. Lett. 2013; 5; 43-48.
21. Sak K. In vitro cytotoxic activity of flavonoids on human ovarian cancer cell lines. Cancer Sci. Res. Open Access. 2015; 2(1): 1-13.
22. Anantharaju PG, Gowda PC, Vimalambike MG, Madhunapantula SV. An overview on the role of dietary phenolics for the treatment of cancers. Nut. J. 2016; 15: 99.
23. Gong X, Smith JR, Swanson HM, Rubin LP. Carotenoid lutein selectively inhibits breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms. Molecules. 2018; 23(4): 905.
24. Habli Z, Toumieh G, Faffat M, Rahal ON, Gali-Muhtasib H. Emerging cytotoxic alkaloids in the battle against cancer: overview of molecular mechanisms. Molecules. 2017; 22(2): 250.
Received on 05.06.2020 Modified on 10.07.2020
Accepted on 23.07.2020 © RJPT All right reserved
Research J. Pharm. and Tech. 2021; 14(6):3389-3392.
DOI: 10.52711/0974-360X.2021.00589